As the ₹60.15 crore Novus Loyalty IPO enters its penultimate day on March 19, 2026, the retail segment is leading the charge with 1.22x subscription. While the Grey Market Premium (GMP) remains steady at ₹0, the company’s pivot toward AI-powered rewards and its expansion into the USA and Australia are keeping long-term tech investors interested. We break down the latest subscription figures and what to expect for the final day.
The ₹400 crore GSP Crop Science IPO reaches its conclusion today, March 18, 2026. With institutional (QIB) and high-net-worth (NII) categories already comfortably over the finish line, the total subscription has crossed the 1x mark. However, with a ₹0 Grey Market Premium and a quiet retail segment, we analyze if this is a value-buy for the long term.
Industrial machinery specialist Tipco Engineering India Limited is set to launch its ₹60.55 crore SME IPO on March 23, 2026. With a diverse portfolio ranging from bead mills to homogenizers and a massive 92% revenue CAGR, the company is positioning itself as a key beneficiary of India's manufacturing push. Priced at ₹84–₹89, we dive into the financials and "Turnkey" growth strategy behind this Haryana-based manufacturer.
Gurgaon-based Novus Loyalty is in the middle of its ₹60.15 crore SME IPO (March 17–20, 2026). Following a Day 1 subscription of 0.83x, the issue is seeing a steady climb today. While the Grey Market Premium (GMP) remains flat at ₹0, the company’s recent profit jump in H1 FY26 is drawing the attention of long-term risk-seekers. We break down the Day 2 pulse and the "aggressive" vs. "value" pricing debate.
Gurgaon-based Novus Loyalty launched its ₹60.15 crore SME IPO today, March 17, 2026. With a price band of ₹139–₹146, the company is leveraging its AI-powered platform to serve giants in fintech and banking. This blog covers the Day 1 subscription start, the impressive 40% ROCE, and why the grey market is currently playing it cool.
Ahmedabad-based GSP Crop Science is currently in the middle of its ₹400 crore mainboard IPO (March 16–18, 2026). While the issue saw a solid 47% subscription on its opening day—driven primarily by institutional interest—the grey market remains flat. We break down the Day 2 pulse, the 18x valuation, and whether the debt-reduction strategy makes it a long-term winner.
Mumbai-based Speciality Medicines Limited is set to launch its ₹29.14 crore SME IPO on March 20, 2026. Specializing in high-value therapies like oncology and neurology across 35 countries, the company is pricing its issue at ₹117–₹124. With a massive 200% profit jump in FY25 and plans for a dedicated R&D center, we look at whether this "specialty" play deserves a spot in your portfolio.
Coal India’s consultancy arm, Central Mine Planning & Design Institute (CMPDI), is launching its ₹1,842.12 crore IPO on March 20, 2026. As a debt-free "Mini Ratna" with a 61% market share in mining consultancy, the company is attracting early grey market interest. With a price band of ₹163–₹172 and an 11-13% estimated listing gain, we explore if this PSU gem is a "must-subscribe" for your portfolio.
The ₹306 crore Innovision Limited IPO officially closes today, March 17, 2026. After a slow start led to a revised price band of ₹494–₹519 and a 5-day extension, institutional investors have finally moved in. With the overall subscription crossing 1.2x and a recovering GMP, we look at the final numbers before the window shuts at 5:00 PM.
Gujarat-based GSP Crop Science launched its ₹400 crore mainboard IPO today, March 16, 2026. With a price band of ₹304–₹320, the company is showcasing an incredible 360% profit surge since FY23. This blog breaks down the Day 1 subscription pulse, the ₹170 crore debt-reduction plan, and why analysts are keeping a "Neutral" but watchful eye on this agrochemical giant.
Gurgaon-based Novus Loyalty Limited is set to launch its ₹60.15 crore SME IPO on March 17, 2026. Specializing in AI-powered loyalty platforms for giants in the Fintech and Banking sectors, the company has seen its revenue soar to over ₹100 crore. With a price band of ₹139–₹146, we look at whether this "low-margin, high-growth" tech play belongs in your portfolio.
Gurgaon-based Innovision Limited has extended its ₹306 crore IPO until March 17, 2026, after a tepid initial response. To sweeten the deal, the company has slashed its price band to ₹494–₹519. With a high ROE of 35% but heavy reliance on NHAI contracts, we break down if this revised valuation makes it a better bet for your portfolio.
GMP IPO Watch
Open IPO
